Rapidly progressive soft tissue infections

Lancet Infectious Diseases

Volumn 5, Issue 8, 2005, Pages 501-513

  Vinh, Donald C ^a   Embil, John M ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; DOXYCYCLINE; GATIFLOXACIN; GLYCOPEPTIDE; IMMUNOGLOBULIN; LEVOFLOXACIN; LINEZOLID; MACROLIDE; METRONIDAZOLE; MINOCYCLINE; MOXIFLOXACIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNINDEXED DRUG;

AEROMONAS HYDROPHILA; ANTIMICROBIAL THERAPY; CLINICAL FEATURE; CLOSTRIDIUM PERFRINGENS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; ENTEROBACTERIACEAE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERBARIC OXYGEN; LEECH; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NORTH AMERICA; OUTPATIENT; PASTEURELLA; PATHOGENESIS; PATHOPHYSIOLOGY; PHLEBOTOMY; PRIORITY JOURNAL; PSEUDOMONAS; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; STREPTOCOCCUS; STREPTOCOCCUS GROUP A; TREATMENT INDICATION; VIBRIO;

ANIMALS; ANTI-BACTERIAL AGENTS; HOSPITALIZATION; HUMANS; SEVERITY OF ILLNESS INDEX; SKIN DISEASES, INFECTIOUS; SOFT TISSUE INFECTIONS; STREPTOCOCCUS PYOGENES; VIBRIO;

EID: 22544467299     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(05)70191-2     Document Type: Review

References (148)

1. Dong SL, Kelly KD, Oland RC, Holroyd BR, Rowe BH ED management of cellulitis: a review of five urban centers Am J Emerg Med 19 2001 535 540
2. MJ DiNubile, BA Lipsky Complicated infections of skin and skin structures: when the infection is more than skin deep J Antimicrob Chemother 53 2004 37 50
3. MN Swartz Clinical practice. Cellulitis N Engl J Med 350 2004 904 912
4. LJ Eron, BA Lipsky, DE Low Managing skin and soft tissue infections: expert panel recommendations on key decision points J Antimicrob Chemother 52 2003 3 17
5. HB Fung, JY Chang, S Kuczynski A practical guide to the treatment of complicated skin and soft tissue infections Drugs 63 2003 1459 1480
6. BA Lipsky, AR Berendt, HG Deery Diagnosis and treatment of diabetic foot infections Clin Infect Dis 39 2004 885 910
7. N Zetola, JS Francis, EL Nuermberger, WR Bishai Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat Lancet Infect Dis 5 2005 275 286
8. PM Newell Norden CW Value of needle aspiration in bacteriologic diagnosis of cellulitis in adults J Clin Microbiol 26 1988 401 404
9. EW Hook, TM Hooton, CA Horton, MB Coyle, PG Ramsey, M Turck Microbiologic evaluation of cutaneous cellulitis in adults Arch Intern Med 146 1986 295 297
10. Y Horowitz, A Sperber, Y Almog Gram-negative cellulitis complicating cirrhosis Mayo Clin Proc 79 2004 247 250
11. CR McHenry, CP Brandt, JJ Piotrowski, DG Jacobs, MA Malangoni Idiopathic necrotizing fasciitis: recognition, incidence, and outcome of therapy Am Surg 60 1994 490 494
12. CR McHenry, JJ Piotrowski, D Petrinic, MA Malangoni Determinants of mortality for necrotizing soft-tissue infections Ann Surg 221 1995 558 563
13. RL Nichols, S Floman Clinical presentations of soft-tissue infections and surgical site infections Clin Infect Dis 33 2001 S84 S93
14. JD Cunningham, L Silver, D Rudikoff Necrotizing fasciitis: a plea for early diagnosis and treatment Mt Sinai J Med 68 2001 253 261
15. RJ Green, DC Dafoe, TA Raffin Necrotizing fasciitis Chest 110 1996 219 229
16. JD Urschel Necrotizing soft tissue infections Postgrad Med J 75 1999 645 649
17. EK Chapnick, EI Abter Necrotizing soft-tissue infection Inf Dis Clin N Am 10 1996 835 855
18. D Elliott, J Kufera, RA Myers The microbiology of necrotizing soft tissue infections Am J Surg 179 2000 361 366
19. DJ Hoadley, EJ Mark Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 28-2002. A 35 year-old long-term traveler with a rapidly progressive soft-tissue infection N Engl J Med 347 2002 831 837
20. DA Talan, DM Citron, FM Abrahamian Bacteriologic analysis of infected dog and cat bites N Engl J Med 340 1999 85 92
21. DP Francis, M Holmes, G Brandon Pasteurella multocida. Infections after domestic animal bites and scratches JAMA 233 1975 42 45
22. M Borenstein, F Kerdel Infection with Vibrio vlunificus Dermatology Clincs 21 2003 245 248
23. MA Gardam, D Low, R Saginur, MA Miller Group B streptococcal necrotizing fasciitis and streptococcal toxic shock-like syndrome in adults Arch Intern Med 158 1998 1704 1708
24. CH Wong, A Kurup, KC Tan Group B Streptococcus necrotizing fasciitis: an emerging disease? Eur J Clin Microbiol Infect Dis 23 2004 573 575
25. NF Crum, MR Wallace Group B streptococcal necrotizing fasciitis and toxic shock-like syndrome: a case report and review of the literature Scand J Infect Dis 35 2003 878 881
26. M Sharma, R Khatib, M Fakih Clinical characteristics of necrotizing fasciitis caused by group G streptococcus: case report and review of the literature Scand J Infect Dis 34 2002 468 471
27. CH Wong, A Kurup, YS Wang, KS Heng, KC Tan Four cases of necrotizing fasciitis caused by Klebsiella species Eur J Clin Microbiol Infect Dis 23 2004 403 407
28. S Liangpunsakul, K Pursell Community-acquired necrotizing fasciitis caused by Serratia marcescens: case report and review Eur J Clin Microbiol Infect Dis 20 2001 509 510
29. JF Silvestre, M Betlloch Cutaneous manifestations due to Pseudomonas infection Int J Dermatol 38 1999 419 431
30. EM Begier, K Frenette, NL Barrett A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns Clin Infect Dis 39 2004 1446 1453
31. P Koutkia, E Mylonakis, J Boyce Cellulitis: evaluation of possible predisposing factors in hospitalized patients Diagn Microbiol Infect Dis 34 1999 325 327
32. AL Bisno, DL Stevens Streptococcal infections of skin and soft tissues N Engl J Med 334 1996 240 245
33. AL Bisno Streptococcus pyogenes 5th edn. Mandell GL Bennett JE Dolin R Mandell, Douglas, and Bennett's principles and practice of infectious diseases vol 1 2000 Churchill Livingstone New York 1786 1799
34. JM Bonnetblanc, C Bedane Erysipelas: recognition and management Am J Clin Dermatol 4 2003 157 163
35. N Coste, G Perceau, J Leone, P Young, F Carsuzaa, K Bernardeau, P Bernard Osteoarticular complications of erysipelas J Am Acad Dermatol 50 2004 203 209
36. P Bernard, D Christmann, M Morel Management of erysipelas in French hospitals: a post-consensus conference study Ann Dermatol Venereol 132 2005 213 217 (in French)
37. S Mossad Common infections in clinical practice: dealing with the daily uncertainties Cleve Clin J Med 71 2004 129 143
38. J Darenberg, N Ihendyane, J Sjolin Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial Clin Infect Dis 37 2003 333 340
39. CH Wong, H Chang, S Pasupathy Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality J Bone Joint Surg Am 85-A 2003 1454 1460
40. TM File Necrotizing soft tissue infections Curr Infect Dis Rep 5 2003 407 415
41. C Sikora, J Speilman, K Macdonald, G Tyrrell, J Embil, Bite wound associated necrotizing fasciitis. Can J Infect Dis Med Microbiol (in press).
42. KL Fox, M Born, MA Cohen Fulminant infection and toxic shock syndrome caused by Streptococcus pyogenes J Emerg Med 22 2002 357 366
43. DM Aronoff, K Bloch Assessing the relationship between the use of nonsteroidal antiinflammatory drugs and necrotizing fasciitis caused by group A streptococcus Medicine (Baltimore) 82 2003 225 235
44. HD Davies, A McGeer, B Schwartz Invasive group A streptococcal infections in Ontario, Canada N Engl J Med 335 1996 547 554
45. The Working Group on Severe Streptococcal Infections Defining the group A streptococcal toxic shock syndrome JAMA 269 1993 390 391
46. DV Seal Necrotizing fasciitis Curr Opin Infect Dis 14 2001 127 132
47. CH Wong, L Khin, KS Heng, KC Tan, CO Low The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections Crit Care Med 32 2004 1535 1541
48. DL Stevens Streptococcal toxic shock syndrome associated with necrotizing fasciitis Annu Rev Med 51 2000 271 288
49. Simonart T, Simonart JM, Derdelinckx I Value of standard laboratory tests for the early recognition of group A beta-hemolytic streptococcal necrotizing fasciitis Clin Infect Dis 32 2001 E9 E12
50. CW Stratton, S Brown Comparative in vitro activity of telithromycin and beta-lactam antimicrobials against community-acquired bacterial respiratory tract pathogens in the United States: findings from the PROTEKT US study, 2000-2001 Clin Ther 26 2004 522 530
51. A Tillou, CR St Hill, C Brown, G Velmahos Necrotizing soft tissue infections: improved outcomes with modern care Am Surg 70 2004 841 844
52. J Zimbelman, A Palmer, J Todd Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection Pediatr Infect Dis 18 1999 1096 1100
53. EA Coyle Society of Infectious Diseases Pharmacists Targeting bacterial virulence: the role of protein synthesis inhibitors in severe infections. Insights from the Society of Infectious Diseases Pharmacists Pharmacotherapy 23 2003 638 642
54. A Norrby-Teglund, N Ihendyane, J Darenberg Intravenous immunoglobulin adjunctive therapy in sepsis, with special emphasis on severe invasive group A streptococcal infections Scand J Infect Dis 35 2003 683 689
55. DL Stevens Dilemmas in the treatment of invasive Streptococcus pyogenes infections Clin Infect Dis 37 2003 341 343
56. AC Kimura, JI Higa, RM Levin, G Simpson, Y Vargas, DJ Vugia Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users Clin Infect Dis 38 2004 e87 e91
57. DR Bangsberg, JI Rosen, T Aragon, A Campbell, L Weir, F Perdreau-Remington Clostridial myonecrosis cluster among injection drug users: a molecular epidemiology investigation Arch Intern Med 162 2002 517 522
58. JR Ebright, B Pieper Skin and soft tissue infections in injection drug users Infect Dis Clin North Am 16 2002 697 712
59. DL Stevens, BM Laine, JE Mitten Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringens Antimicrob Agents Chemother 31 1987 312 316
60. EP Kindwall Uses of hyperbaric oxygen therapy in the 1990s Cleve Clin J Med 59 1992 517 528
61. MB Stephens Gas gangrene: potential for hyperbaric oxygen therapy Postgrad Med 99 1996 217 220
62. N Jallali, S Withey, PE Butler Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis Am J Surg 189 2005 462 466
63. PY Donnio, AL Lerestif-Gautier, JL Avril Characterization of Pasteurella spp. strains isolated from human infections J Comp Pathol 130 2004 137 142
64. EJ Goldstein, DM Citron, SM Finegold Role of anaerobic bacteria in bite-wound infections Rev Infect Di 6 1984 S177 S183
65. Y Hamamoto, Y Soejima, M Ogasawara, H Okimura, K Nagai, C Asagami Necrotizing fasciitis due to Pasteurella multocida infection Dermatology 190 1995 145 149
66. JJ Zurlo Pasteurella species 5th edn Mandell GL Bennett JE Dolin R Mandell, Douglas, and Bennett's principles and practice of infectious diseases vol 2 2000 Churchill Livingstone Philadelphia 2403 2406
67. SD Boles, CC Schmidt Pyogenic flexor tenosynovitis Hand Clin 14 1998 567 578
68. JE Mortensen, O Giger, GL Rodgers In vitro activity of oral antimicrobial agents against clinical isolates of Pasteurella multocida Diagn Microbiol Infect Dis 30 1998 99 102
69. FM Abrahamian Dog bites: bacteriology, management, and prevention Curr Infect Dis Rep 2 2000 446 453
70. RD Griego, T Rosen, IF Orengo, JE Wolf Dog, cat, and human bites: a review J Am Acad Dermatol 33 1995 1019 1029
71. JS Winner, CA Gentry, LJ Machado, P Cornea Aztreonam treatment of Pasteurella multocida cellulitis and bacteremia Ann Pharmacother 37 2003 392 394
72. GJ Noel, DW Teele In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida Antimicrob Agents Chemother 29 1986 344 345
73. EJ Goldstein, DM Citron, GA Richwald Lack of in vitro efficacy of oral forms of certain cephalosporins, erythromycin, and oxacillin against Pasteurella multocida Antimicrob Agents Chemother 32 1988 213 215
74. MP Grobusch, K Gobels, D Teichmann Cellulitis and septicemia caused by Aeromonas hydrophila acquired at home Infection 29 2001 109 110
75. JM Janda, SL Abbott Evolving concepts regarding the genus Aeromonas: an expanding panorama of species, disease presentations, and unanswered questions Clin Infect Dis 27 1998 332 344
76. JP Steinberg, C Del Rio Other Gram-negative bacilli 5th edn Mandell GL Bennet JE Dolin R Mandell, Douglas, and Bennett's principles and practice of infectious diseases Vol 2 2000 Churchill Livingstone Philadelphia 2460 2462
77. DM Musher Cutaneous and soft-tissue manifestations of sepsis due to gram-negative enteric bacilli Rev Infect Dis 2 1980 854 866
78. L Elko, K Rosenbach, J Sinnott Cutaneous manifestations of waterborne infections Curr Infect Dis Rep 5 2003 398 406
79. DR Mackay, EK Manders, GC Saggers, DR Banducci, J Prinsloo, K Klugman Aeromonas species isolated from medicinal leeches Ann Plast Surg 42 1999 275 279
80. C Sartor, F Limouzin-Perotti, R Legre Nosocomial infections with Aeromonas hydrophila from leeches Clin Infect Di 35 2002 E1 E5
81. DP Snower, C Ruef, AP Kuritza, SC Edberg Aeromonas hydrophila infection associated with the use of medicinal leeches J Clin Microbiol 27 1989 1421 1422
82. WC Lineaweaver, M Hill, GM Buncke Aeromonas hydrophila infections following use of medicinal leeches in replantation and flap surgery Ann Plast Surg 29 1992 238 244
83. SM Lau, M Peng, FY Chang Outcomes of Aeromonas bacteremia in patients with different types of underlying disease J Microbiol Immunol Infect 33 2000 241 247
84. WC Ko, HC Lee, YC Chuang, CC Liu, JJ Wu Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia J Infect 40 2000 267 273
85. DR Haburchak Aeromonas hydrophila: an underappreciated danger to fisherman Infect Med 13 1996 893 896
86. S Mani, M Sadigh, VT Andriole Clinical spectrum of Aeromonas hydrophila infections: report of 11 cases in a community hospital and review Infect Dis Clin Pract 4 1995 79 86
87. WG Hlady, RC Mullen, RS Hopkin Vibrio vulnificus from raw oysters. Leading cause of reported deaths from foodborne illness in Florida J Fla Med Assoc 80 1993 536 538
88. JG Morris Cholera and other types of vibriosis: a story of human pandemics and oysters on the half shell Clin Inf Dis 37 2003 272 280
89. RL Shapiro, S Altekruse, L Hutwagner The role of Gulf Coast oysters harvested in warmer months in Vibrio vulnificus infections in the United States, 1988-1996. Vibrio Working Group J Infect Dis 178 1998 752 759
90. WG Hlady, KC Klontz The epidemiology of Vibrio infections in Florida. 1981-1993 J Infect Dis 173 1996 1176 1183
91. A DePaola, GM Capers, D Alexander Densities of Vibrio vulnificus in the intestines of fish from the U.S. Gulf Coast Appl Environ Microbiol 60 1994 984 988
92. PR Hsueh, CY Lin, HJ Tang Vibrio vulnificus in Taiwan Emerg Infect Dis 10 2004 1363 1368
93. HJ Tang, MC Chang, WC Ko In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus Antimicrob Agents Chemother 46 2002 3580 3584
94. JC Barton, ME Coghlan, MT Reymann, TW Ozbirn, RT Acton Vibrio vulnificus infection in a hemodialysis patient receiving intravenous iron therapy Clin Inf Di 37 2003 e63 e67
95. SJ Devi, U Hayat, CE Frasch, AS Kreger, JG Morris Jr Capsular polysaccharide-protein conjugate vaccine of carbotype 1 Vibrio vulnificus: construction, immunogenicity, and protective efficacy in a murine model Infect Immun 63 1995 2906 2911
96. LI Hor, TT Chang, ST Wang Survival of Vibrio vulnificus in whole blood from patients with chronic liver diseases: association with phagocytosis by neutrophils and serum ferritin levels J Infect Dis 179 1999 275 278
97. YC Chuang, CY Yuan, CY Liu, CK Lan, AH Huang Vibrio vulnificus infection in Taiwan: report of 28 cases and review of clinical manifestations and treatment Clin Infect Dis 15 1992 271 276
98. JG Morris "Non-cholera" Vibrio species Blaser MJ Smith PD Ravdin JI Greenberg HB Guerrant RL Infections of the gastrointestinal tract 2002 Lippincott, Williams & Wilkins Philadelphia 167 169
99. YC Chuang, JW Liu, WC Ko, KY Lin, JJ Wu, KY Huang In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus Antimicrob Agents Chemother 41 1997 2214 2217
100. YC Chuang, WC Ko, ST Wang, JW Liu, CF Kuo, JJ Wu, KY Huang Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection Antimicrob Agents Chemother 42 1998 1319 1322
101. KD Halow, RC Harner, LJ Fontenelle Primary skin infections secondary to Vibrio vulnificus: the role of operative intervention J Am Coll Surg 183 1996 329 334
102. FD Lowy Staphylococcus aureus infections N Engl J Med 339 1998 520 532
103. DR Guay Treatment of bacterial skin and skin structure infections Expert Opin Pharmacother 4 2003 1259 1275
104. SJ Martin, DG Zeigler The use of fluoroquinolones in the treatment of skin infections Expert Opin Pharmacother 5 2004 237 246
105. A Regev, M Weinberger, M Fishman, Z Samra, SD Pitlik Necrotizing fasciitis caused by Staphylococcus aureus Eur J Clin Microbiol Infect Dis 17 1998 101 103
106. WR Saliba, LH Goldstein, R Raz, R Mader, R Colodner, MS Elias Subacute necrotizing fasciitis caused by gas-producing Staphylococcus aureus Eur J Clin Microbiol Infect Dis 22 2003 612 614
107. EM Bluman, AP Mechrefe, PD Fadale Idiopathic Staphylococcus aureus necrotizing fasciitis of the upper extremity J Shoulder Elbow Surg 14 2005 227 230
108. C Bodemer, A Panhans, B Chretien-Marquet, M Cloup, D Pellerin, Y de Prost Staphylococcal necrotizing fasciitis in the mammary region in childhood: a report of five cases J Pediatr 131 1997 466 469
109. DM Livermore Antibiotic resistance in staphylococci Int J Antimicrob Agent 16 2000 S3 S10
110. N Woodford Biological counterstrike: antibiotic resistance mechanisms of Gram-positive cocci Clin Microbiol Infect 11 2005 2 21
111. MC Lee, AM Rios, MF Aten Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus Pediatr Infect Dis J 23 2004 123 127
112. KM Campbell, AF Vaughn, KL Russell Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002 J Clin Microbiol 42 2004 4050 4053
113. DM Nguyen, L Mascola, E Brancoft Recurring methicillin-resistant Staphylococcus aureus infections in a football team Emerg Infect Dis 11 2005 526 532
114. G Lina, Y Piemont, F Godail-Gamot Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia Clin Infect Dis 29 1999 1128 1132
115. B Cribier, G Prevost, P Couppie, V Finck-Barbancon, E Grosshans, Y Piemont Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study Dermatology 185 1992 175 180
116. PR Cohen, R Kurzrock Community-acquired methicillin-resistant Staphylococcus aureus skin infection: an emerging clinical problem J Am Acad Dermatol 50 2004 277 280
117. LG Miller, F Perdreau-Remington, G Rieg Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles N Engl J Med 352 2005 1445 1453
118. Lewis JS 2nd, JH Jorgensen Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned? Clin Infect Dis 40 2005 280 285
119. NA Rezende, HM Blumberg, BS Metzger, NM Larsen, SM Ray, JE McGowan Jr Risk factors for methicillin-resistance among patients with Staphylococcus aureus bacteremia at the time of hospital admission Am J Med Sci 323 2002 117 123
120. V Levy, C Reed, SL Abbott, D Israelski Escherichia coli myonecrosis in alcoholic cirrhosis J Clin Gastroenterol 36 2003 443 445
121. JE Gach, R Charles-Holmes, A Ghose E. coli cellulitis Clin Exp Dermatol 27 2002 523 525
122. DL Paterson, S Gruttadauria, A Lauro, V Scott, IR Marino Spontaneous gram-negative cellulitis in a liver transplant recipient Infection 29 2001 345 347
123. TY Yoon, SK Jung, SH Chang Cellulitis due to Escherichia coli in three immunocompromised subjects Br J Dermatol 139 1998 885 888
124. C Bachmeyer, M Sanguina, Y Turc, G Reynaert, L Blum Necrotizing fasciitis due to Serratia marcescens Clin Exp Dermatol 29 2004 673 674
125. JW Huang, CT Fang, KY Hung, PR Hsueh, SC Chang, TJ Tsai Necrotizing fasciitis caused by Serratia marcescens in two patients receiving corticosteroid therapy J Formos Med Assoc 98 1999 851 854
126. CE Curtis, S Chock, T Henderson, MJ Holman A fatal case of necrotizing fasciitis caused by Serratia marcescens Am Surg 71 2005 228 230
127. JM Corredoira, J Ariza, R Pallares Gram-negative bacillary cellulitis in patients with hepatic cirrhosis Eur J Clin Microbiol Infect Dis 13 1994 19 24
128. NF Crum, M Wallace Serratia marcescens cellulitis: a case report and review of the literature Infect Dis Clin Pract 11 2002 550 554
129. A Hejazi, FR Falkiner Serratia marcescens J Med Microbiol 46 1997 903 912
130. A Kumar, EA Worobec Fluoroquinolone resistance of Serratia marcescens: involvement of a proton gradient-dependent efflux pump J Antimicrob Chemother 50 2002 593 596
131. WA Agger, A Mardan Pseudomonas aeruginosa infections of intact skin Clin Infect Dis 20 1995 302 308
132. SL Greene, WP Su, SA Muller. Pseudomonas aeruginosa infections of the skin Am Fam Physician 29 1984 193 200
133. H Gucluer, T Ergun, Z Demircay Ecthyma gangrenosum Int J Dermatol 38 1999 299 302
134. EJ Kim, M Foad, R Travers Ecthyma gangrenosum in an AIDS patient with normal neutrophil count J Am Acad Dermatol 41 1999 840 841
135. HL Reich, D Williams Fadeyi, NS Naik, PJ Honig, AC Yan Nonpseudomonal ecthyma gangrenosum J Am Acad Dermatol 50 2004 S114 S117
136. P el Baze, A Thyss, H Vinti, A Deville, P Dellamonica, JP Ortonne A study of nineteen immunocompromised patients with extensive skin lesions caused by Pseudomonas aeruginosa with and without bacteremia Acta Derm Venereol 71 1991 411 415
137. WK Song, YC Kim, HJ Park, YW Cinn Ecthyma gangrenosum without bacteraemia in a leukaemic patient Clin Exp Dermatol 26 2001 395 397
138. AM Boisseau, J Sarlangue, Y Perel, JP Hehunstre, A Taieb, J Maleville Perineal ecthyma gangrenosum in infancy and early childhood: septicemic and nonsepticemic forms J Am Acad Dermatol 27 1992 415 418
139. D Huminer, Y Siegman-Igra, G Morduchowicz, SD Pitlik Ecthyma gangrenosum without bacteremia. Report of six cases and review of the literature Arch Intern Med 147 1987 299 301
140. JE Fergie, CC Patrick, L Lott Pseudomonas aeruginosa cellulitis and ecthyma gangrenosum in immunocompromised children Pediatr Infect Dis J 10 1991 496 500
141. L Aliaga, JD Mediavilla, F Cobo A clinical index predicting mortality with Pseudomonas aeruginosa bacteraemia J Med Microbiol 51 2002 615 619
142. SA Zelenitsky, GK Harding, S Sun, K Ubhi, RE Ariano Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis J Antimicrob Chemother 52 2003 668 674
143. M Hilf, VL Yu, J Sharp, JJ Zuravleff, JA Korvick, RR Muder Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients Am J Med 87 1989 540 546
144. N Safdar, J Handelsman, DG Maki Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis Lancet Infect Dis 4 2004 519 527
145. E Chamot, E Boffi El Amari, P Rohner, C Van Delden Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia Antimicrob Agents Chemother 47 2003 2756 2764
146. ST Micek, AE Lloyd, DJ Ritchie, RM Reichley, VJ Fraser, MH Kollef Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment Antimicrob Agents Chemother 49 2005 1306 1311
147. RK Reed, WE Larter, OF Sieber Jr, TJ John Peripheral nodular lesions in Pseudomonas sepsis. The importance of incision and drainage J Pediatr 88 1976 977 979
148. KA Picou, MT Jarratt Persistent subcutaneous abscesses following Pseudomonas sepsis. Treatment by surgical incision and drainage Arch Dermatol 115 1979 459 460